Yasumasa Monden Selected Research

Yasumasa Monden Research Topics

Disease

10	Neoplasms (Cancer) 10/2005 - 03/2002
7	Lung Neoplasms (Lung Cancer) 09/2006 - 01/2002
5	Thymoma (Thymic Carcinoma) 07/2005 - 09/2003
4	Carcinogenesis 09/2006 - 03/2002
3	Breast Neoplasms (Breast Cancer) 12/2004 - 03/2002
2	Atherosclerosis 12/2012 - 09/2011
2	Neoplasm Metastasis (Metastasis) 09/2005 - 03/2004
2	Lymphatic Metastasis 09/2005 - 03/2004
2	Microsatellite Instability 03/2005 - 03/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2005 - 11/2003
1	Insulin Resistance 12/2012
1	Hyperlipidemias (Hyperlipidemia) 09/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2011
1	Coronary Disease (Coronary Heart Disease) 09/2011
1	Metaplasia 10/2005
1	Hyperplasia 10/2005
1	Body Weight (Weight, Body) 09/2005
1	Myasthenia Gravis 07/2005
1	Plasmacytoma 05/2005
1	Endometrial Neoplasms (Endometrial Cancer) 12/2004
1	Blister (Bulla) 06/2004
1	Neoplasm Micrometastasis 03/2004
1	Carcinoma (Carcinomatosis) 12/2003
1	Carcinoid Tumor (Carcinoid) 09/2003
1	Stomach Neoplasms (Stomach Cancer) 01/2003
1	Colonic Neoplasms (Colon Cancer) 02/2002
1	Aberrant Crypt Foci 02/2002

Drug/Important Bio-Agent (IBA)

5	ChromatesIBA 09/2006 - 03/2002
4	Proteins (Proteins, Gene)FDA Link 09/2006 - 11/2003
4	ChromiumIBA 09/2006 - 03/2002
2	Lipoproteins (Lipoprotein)IBA 12/2012 - 09/2011
2	CarcinogensIBA 09/2006 - 12/2003
2	Matrix Metalloproteinases (MMPs)IBA 09/2005 - 11/2003
2	Messenger RNA (mRNA)IBA 03/2005 - 11/2004
2	Indicators and Reagents (Reagents)IBA 01/2005 - 04/2004
2	DNA AdductsIBA 12/2004 - 01/2003
2	SuspensionsIBA 11/2004 - 11/2003
2	doxifluridineIBA 03/2003 - 03/2002
1	oxidized low density lipoproteinIBA 12/2012
1	CholesterolIBA 12/2012
1	AdiponectinIBA 12/2012
1	Triglycerides (Triacylglycerol)IBA 09/2011
1	Apolipoprotein B-48IBA 09/2011
1	ChylomicronsIBA 09/2011
1	Cyclin-Dependent Kinase Inhibitor p16IBA 09/2006
1	Matrix Metalloproteinase InhibitorsIBA 09/2005
1	N-alpha-(4-(2-phenyl-2H- tetrazole-5-yl) phenyl sulfonyl)-D-tryptophanIBA 09/2005
1	Immunoglobulin D (IgD)IBA 05/2005
1	UracilIBA 03/2005
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 03/2005
1	TegafurIBA 03/2005
1	A-Form DNA (A-DNA)IBA 03/2005
1	Thymidylate SynthaseIBA 03/2005
1	Tamoxifen FDA LinkGeneric 12/2004
1	Estrogen Receptor Modulators (Antiestrogen)IBA 12/2004
1	DNA (Deoxyribonucleic Acid)IBA 12/2004
1	Complementary DNA (cDNA)IBA 11/2004
1	Dihydrotachysterol (AT 10)IBA 04/2004
1	A 17 (A-17)IBA 04/2004
1	Green Fluorescent ProteinsIBA 03/2004
1	EnzymesIBA 11/2003
1	Tissue Inhibitor of Metalloproteinase-1IBA 11/2003
1	Tissue Inhibitor of Metalloproteinase-2IBA 11/2003
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 11/2003
1	CollagenIBA 11/2003
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2003
1	Capecitabine (Xeloda)FDA Link 03/2002
1	Bile Acids and Salts (Bile Acids)IBA 02/2002
1	AzoxymethaneIBA 02/2002
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 02/2002

Therapy/Procedure

3	Therapeutics 12/2004 - 01/2002
2	Adjuvant Chemotherapy 03/2005 - 03/2003
2	Drug Therapy (Chemotherapy) 03/2004 - 09/2003
1	Thymectomy 07/2005
1	Chemoprevention 12/2004
1	Local Anesthesia 06/2004
1	Transplantation 03/2004
1	Radiotherapy 09/2003